EHS
EHS

Pharmalittle: Trump officials urge drug makers to lower prices; Drug dealers are sued for creating opioid crisis

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest this time around. We plan to hang with a couple of our short people and check in on the Pharmalot ancestors. Beyond that, a few naps are in order. And what about you? Summer is in full swing, so perhaps you can enjoy the great outdoors – beaches, lakes and mountains are beckoning. You may want to touch base with someone special or catch up on your reading. You could also place bets on whether another summit takes place at the White House. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon…

President Trump met with Pfizer (PFE) chief executive Ian Read at the White House on Thursday as the administration pressures drug makers to voluntarily rein in prices, according to Politico. Separately, four officials from the U.S. Department of Health and Human Services — including Deputy Secretary Eric Hargan and Dan Best, the agency’s point person on drug pricing — met with pharmaceutical executives to reinforce the administration message to lower prices and press for more action. Sanofi (SNY), Roche (RHHBY) and Merck KGaA also reportedly agreed not to raise prices this year, CNBC says.

Read the rest…

EHS
Back to top button